113 related articles for article (PubMed ID: 9371489)
21. Induction of apoptosis in MCF-7 breast carcinoma cell line by RAR and RXR selective retinoids.
Toma S; Isnardi L; Riccardi L; Bollag W
Anticancer Res; 1998; 18(2A):935-42. PubMed ID: 9615744
[TBL] [Abstract][Full Text] [Related]
22. Expression of retinoic acid receptor beta in human renal cell carcinomas correlates with sensitivity to the antiproliferative effects of 13-cis-retinoic acid.
Hoffman AD; Engelstein D; Bogenrieder T; Papandreou CN; Steckelman E; Dave A; Motzer RJ; Dmitrovsky E; Albino AP; Nanus DM
Clin Cancer Res; 1996 Jun; 2(6):1077-82. PubMed ID: 9816270
[TBL] [Abstract][Full Text] [Related]
23. Cyclin D1 and associated proteins in mammary ductal carcinoma in situ and atypical ductal hyperplasia.
Gillett CE; Lee AH; Millis RR; Barnes DM
J Pathol; 1998 Apr; 184(4):396-400. PubMed ID: 9664905
[TBL] [Abstract][Full Text] [Related]
24. An EGF receptor inhibitor induces RAR-beta expression in breast and ovarian cancer cells.
Grunt TW; Puckmair K; Tomek K; Kainz B; Gaiger A
Biochem Biophys Res Commun; 2005 Apr; 329(4):1253-9. PubMed ID: 15766561
[TBL] [Abstract][Full Text] [Related]
25. Cyclin D1 gene amplification and overexpression are present in ductal carcinoma in situ of the breast.
Vos CB; Ter Haar NT; Peterse JL; Cornelisse CJ; van de Vijver MJ
J Pathol; 1999 Feb; 187(3):279-84. PubMed ID: 10398079
[TBL] [Abstract][Full Text] [Related]
26. [Retinoic acid nuclear receptor beta (RAR beta) inhibits breast carcinoma growth].
Shao Z; Shen Z
Zhonghua Zhong Liu Za Zhi; 1996 Sep; 18(5):324-7. PubMed ID: 9387266
[TBL] [Abstract][Full Text] [Related]
27. Increase of GKLF messenger RNA and protein expression during progression of breast cancer.
Foster KW; Frost AR; McKie-Bell P; Lin CY; Engler JA; Grizzle WE; Ruppert JM
Cancer Res; 2000 Nov; 60(22):6488-95. PubMed ID: 11103818
[TBL] [Abstract][Full Text] [Related]
28. Hypermethylation does not account for the frequent loss of the retinoic acid receptor beta2 in breast carcinoma.
Yang Q; Sakurai T; Yoshimura G; Mori I; Nakamura M; Nakamura Y; Suzuma T; Tamaki T; Umemura T; Kakudo K
Anticancer Res; 2001; 21(3B):1829-33. PubMed ID: 11497266
[TBL] [Abstract][Full Text] [Related]
29. Suppression of retinoic acid receptor beta in non-small-cell lung cancer in vivo: implications for lung cancer development.
Xu XC; Sozzi G; Lee JS; Lee JJ; Pastorino U; Pilotti S; Kurie JM; Hong WK; Lotan R
J Natl Cancer Inst; 1997 May; 89(9):624-9. PubMed ID: 9150186
[TBL] [Abstract][Full Text] [Related]
30. Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ.
De Leeuw WJ; Berx G; Vos CB; Peterse JL; Van de Vijver MJ; Litvinov S; Van Roy F; Cornelisse CJ; Cleton-Jansen AM
J Pathol; 1997 Dec; 183(4):404-11. PubMed ID: 9496256
[TBL] [Abstract][Full Text] [Related]
31. Similarity in expression of cell cycle proteins between in situ and invasive ductal breast lesions of same differentiation grade.
Mommers EC; Leonhart AM; Falix F; Michalides R; Meijer CJ; Baak JP; Diest PJ
J Pathol; 2001 Jul; 194(3):327-33. PubMed ID: 11439365
[TBL] [Abstract][Full Text] [Related]
32. Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ.
Half E; Tang XM; Gwyn K; Sahin A; Wathen K; Sinicrope FA
Cancer Res; 2002 Mar; 62(6):1676-81. PubMed ID: 11912139
[TBL] [Abstract][Full Text] [Related]
33. Retinoids and retinoic acid receptors regulate growth arrest and apoptosis in human mammary epithelial cells and modulate expression of CBP/p300.
Dietze EC; Caldwell LE; Marcom K; Collins SJ; Yee L; Swisshelm K; Hobbs KB; Bean GR; Seewaldt VL
Microsc Res Tech; 2002 Oct; 59(1):23-40. PubMed ID: 12242694
[TBL] [Abstract][Full Text] [Related]
34. Increased estrogen receptor betacx expression during mammary carcinogenesis.
Esslimani-Sahla M; Kramar A; Simony-Lafontaine J; Warner M; Gustafsson JA; Rochefort H
Clin Cancer Res; 2005 May; 11(9):3170-4. PubMed ID: 15867209
[TBL] [Abstract][Full Text] [Related]
35. S100A9 expression in invasive ductal carcinoma of the breast: S100A9 expression in adenocarcinoma is closely associated with poor tumour differentiation.
Arai K; Teratani T; Kuruto-Niwa R; Yamada T; Nozawa R
Eur J Cancer; 2004 May; 40(8):1179-87. PubMed ID: 15110881
[TBL] [Abstract][Full Text] [Related]
36. Expression of oestrogen receptor alpha variants in non-malignant breast and early invasive breast carcinomas.
Chappell SA; Johnson SM; Shaw JA; Walker RA
J Pathol; 2000 Oct; 192(2):159-65. PubMed ID: 11004691
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical expression of human erythrocyte glucose transporter and fatty acid synthase in infiltrating breast carcinomas and adjacent typical/atypical hyperplastic or normal breast tissue.
Alò PL; Visca P; Botti C; Galati GM; Sebastiani V; Andreano T; Di Tondo U; Pizer ES
Am J Clin Pathol; 2001 Jul; 116(1):129-34. PubMed ID: 11447743
[TBL] [Abstract][Full Text] [Related]
38. The localization of the insulin-like growth factor receptor 1 (IGFR-1) in benign and malignant breast tissue.
Happerfield LC; Miles DW; Barnes DM; Thomsen LL; Smith P; Hanby A
J Pathol; 1997 Dec; 183(4):412-7. PubMed ID: 9496257
[TBL] [Abstract][Full Text] [Related]
39. Gene expression and protein deposition of major basement membrane components and TGF-beta 1 in human breast cancer.
Nerlich AG; Wiest I; Wagner E; Sauer U; Schleicher ED
Anticancer Res; 1997; 17(6D):4443-9. PubMed ID: 9494547
[TBL] [Abstract][Full Text] [Related]
40. Up-regulation of retinoic acid receptor beta expression in renal cancers in vivo correlates with response to 13-cis-retinoic acid and interferon-alpha-2a.
Berg WJ; Nanus DM; Leung A; Brown KT; Hutchinson B; Mazumdar M; Xu XC; Lotan R; Reuter VE; Motzer RJ
Clin Cancer Res; 1999 Jul; 5(7):1671-5. PubMed ID: 10430067
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
